Medistream Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.15 M
as on 21-05-2024
About Medistream Biotech
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.15 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dhruvrajsinh Waghela and Neeta Suthar serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC054068
- Company No.
054068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Medistream Biotech Private Limited offer?
Medistream Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Calcium Tablet, Calcium Citrate and Vitamin D3 Tablet, Pharmaceutical Syrup, Oral Suspension, Pharmaceutical Medicine, Lycopene Syrup, Diclofenac, Diclofenac Paracetamol Tablet.
Who are the key members and board of directors at Medistream Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhruvrajsinh Waghela  | Director | 09-Nov-2021 | Current |
| Neeta Suthar | Director | 20-Jan-2009 | Current |
Financial Performance of Medistream Biotech.
Enhance accessibility to Medistream Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medistream Biotech?
In 2016, Medistream Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 20 Jan 2016 | ₹3.50 M | Satisfied |
Bank Of Baroda Creation Date: 14 Sep 2011 | ₹1.65 M | Satisfied |
How Many Employees Work at Medistream Biotech?
Medistream Biotech has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medistream Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medistream Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
